AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

Recruitingn/aAges 18 Years - 85 YearsAllUniversity of Thessaly
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male and female subjects aged 18 - 85 years old. * Clinical symptoms of angina which are classified based on the Canadian Cardiovascular Score (CCS score) * Positive SPECT scan for myocardial ischemia Exclusion Criteria: * Acute Coronary Syndrome 4 weeks before the coronary catheterization * Percutaneous Coronary Angioplasty * Coronary Artery Bypass Graft * Active symptoms of allergy (asthma, urticaria) * Mastocytosis * Hypereosinophilia * Autoimmune disease * Cancer * Kidney failure * Myelodysplastic Syndrome * Denial of signing informed consent
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
417 Military Hospital NIMTS
Athens, Greece
Larisa University Hospital
Larissa, Greece
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy